Glaucoma medical treatment: Philosophy, principles and practice

被引：0
作者：
Clive Migdal
机构：
[1] Western Eye Hospital,
来源：
Eye | 2000年 / 14卷
关键词：
Blood flow; Intraocular pressure; Neuroprotection; Primary open angle glaucoma; Topical medications;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There have been numerous recent advances in the management of glaucoma, not least the development of new drugs to help manage raised intraocular pressure. In addition, the concepts of improving blood flow to the optic nerve head and neuroprotection are currently provoking considerable interest. This article considers the aims and philosophy of glaucoma drug therapy, summarises some of the basic facts and principles of modem glaucoma medications, and suggests a practical approach to the choice of therapy.
引用
收藏
页码：515 / 518
页数：3
相关论文
共 77 条
[1]  
Sommer A(1989)Intraocular pressure and glaucoma Am J Ophthalmol 107 186-8
[2]  
Anderson DR(1989)Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture Am J Ophthalmol 108 485-95
[3]  
Jay JL(1989)The benefit of early trabeculectomy versus conventional medicine in primary open angle glaucoma relative to severity of disease Eye 3 528-35
[4]  
Allan D(1994)Long term functional outcome of early surgery compared with laser and medicine in open angle glaucoma Ophthalmology 101 1651-7
[5]  
Migdal C(1978)The mechanism of timolol in lower intraocular pressure Arch Ophthalmol 96 2045-8
[6]  
Gregory W(1991)A clinical trial of metipranolol, a non-cardioselective beta adrenergic antagonist in ocular hypertension Am J Ophthalmol 112 302-7
[7]  
Hitchings R(1984)Betaxolol and timolol: a comparison of efficacy and side effects Arch Ophthalmol 102 43-5
[8]  
Coakes RL(1984)Ocular beta-blockers and systemic effects Am J Ophthalmol 98 623-16
[9]  
Brubaker RS(1991)MK-507 (L-671, 152): a topically active carbonic anhydrase inhibitor reduces aqueous humor production in monkeys Arch Ophthalmol 109 1297-9
[10]  
Searle JB(1992)Dose-response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor Arch Ophthalmol 100 495-93
12345678